Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | DYAI |
---|---|---|
09:45 ET | 200 | 1.6497 |
09:54 ET | 1200 | 1.6499 |
12:05 ET | 100 | 1.64 |
01:24 ET | 400 | 1.64 |
01:39 ET | 200 | 1.6 |
02:31 ET | 1371 | 1.6399 |
03:07 ET | 480 | 1.625 |
03:14 ET | 250 | 1.62 |
03:45 ET | 500 | 1.61 |
03:50 ET | 1700 | 1.63 |
03:56 ET | 100 | 1.61 |
03:57 ET | 307 | 1.63 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Dyadic International Inc | 47.0M | -6.8x | --- |
eFFECTOR Therapeutics Inc | 49.6M | -0.7x | --- |
Singular Genomics Systems Inc | 38.2M | -0.4x | --- |
Marker Therapeutics Inc | 38.5M | -2.7x | --- |
Unicycive Therapeutics Inc | 50.7M | -0.8x | --- |
Alaunos Therapeutics Inc | 29.8M | -0.8x | --- |
Dyadic International, Inc. is a global biotechnology platform company with operations in the United States. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for industrial applications. This technology is based on the Thermothelomyces heterothallica fungus, namely C1. The C1-cell protein production platform is a robust and versatile thermophilic filamentous fungal expression system for the development and production of biologic products, including enzymes and other proteins for human and animal health. The Company also developed the Dapibus thermophilic filamentous fungal based microbial protein production platform to enable the rapid development and large-scale manufacture of proteins, metabolites and other biologic products for use in non-pharmaceutical applications, such as food, nutrition and wellness.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $47.0M |
---|---|
Revenue (TTM) | $3.0M |
Shares Outstanding | 28.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.58 |
EPS | $-0.24 |
Book Value | $0.39 |
P/E Ratio | -6.8x |
Price/Sales (TTM) | 15.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -280.81% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.